DRAFT 2025 Clinical Guidelines for the Early Detection of Prostate Cancer

>
>
>
DRAFT 2025 Clinical Guidelines for the Early Detection of Prostate Cancer

Go to

Prostate Cancer Foundation of Australia submission to NHMRC: DRAFT 2025 Guidelines for the Early Detection of Prostate Cancer in Australia

Prostate Cancer Foundation of Australia (PCFA) is seeking approval under section 14A of the National Health and Medical Research Council Act 1992 for the DRAFT 2025 Clinical Guidelines for the Early Detection of Prostate Cancer.

The 2025 Guidelines are designed to supersede the 2016 Clinical Practice Guidelines for PSA Testing, recognising that significant advancements in diagnosis and treatment have created an evidence-based pathway for a more structured testing program.

Supporting Documentation

Additional Resources

Media Coverage

View media coverage